Even if galectin-9 can also stimulate natural killer cell proliferation by increasing TIM3+ Kupffer cells' secretion of IL-15, exogenous administration of galectin-9 decreases the development of nonalcoholic fatty liver disease [78]. Here, LGALS9 is linked to metabolic dysfunction-associated steatotic liver disease.